C3 Glomerulonephritis and Neuromyelitis Optica in a Patient with Systemic Lupus Erythematosus (SLE)/Sjogren Overlap Syndrome

Introduction: C3 glomerulopathy (C3G) that includes dense deposit disease (DDD) and C3 glomerulonephritis (C3GN) are rare glomerular disorders triggered by dysregulation of the alternative complement pathway with an estimated incidence of 2-3 cases per million. We describe a rare case of C3GN and neuromyelitis optica in a patient with known SLE/Sjogren overlap syndrome. Case Description: 51-year-old African-American female with SLE/Sjogren overlap syndrome presented with proteinuric AKI on CKD and newly diagnosed transverse myelitis. Baseline Cr 0.8 mg/dL. Labs on admission: Cr 1.7 mg/dL, Sr albumin 2.8 g/dL, UPCR 5511 mg/g, urinalysis revealed acanthocytes. C3 152, C4 38, ANA 1:320 [speckled], ds-DNA (-), SSA > 150, SSB 106, NMO/AQP4 (+) at 1:10000. Rest of serological workup negative. No e/o infection. Kidney USG unremarkable. Kidney biopsy - LM: 35 glomeruli, no segmental or global sclerosis. Glomeruli normal, no endocapillary hypercellularity noted. IFTA <5%. Mild to moderate arterial and arteriolar sclerosis. IF: Fine granular reactivity for C3 [3+] along capillaries and in mesangium that are chunky. Rest of immunoreactants negative. Pronase IF negative. EM: Few scattered medium to large-sized electron dense deposits present in the mesangium and paramesangial area. Alternative complement pathway functional panel revealed low APFA and Fb levels and elevated C5 levels. C3GN genetic panel revealed a VUS in the THBD and MPLA gene. Patient received repeated doses of rituximab and has attained complete remission of proteinuria and resolution of AKI. Discussion: C3GN affecting younger patients usually are mediated by genetic abnormalities of the alternative complement pathway. In addition to renal manifestations, a number of other extra-renal manifestations have also been associated with C3G including retinal involvement [drusen] and lipodystrophy, particularly in DDD. To date, concomitant NMO (+) transverse myelitis presenting concomitantly with C3GN has not been described. It remains unclear if the C3G-dominant immune complex-mediated glomerulonephritis was precipitated by the underlying SLE/Sjogren overlap syndrome.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024t8hfzeyd
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

C3 Glomerulonephritis and Neuromyelitis Optica in a Patient with Systemic Lupus Erythematosus (SLE)/Sjogren Overlap Syndrome

Vijaya Chelikani, Frida Rosenblum, Arun Rajasekaran
Journal of the American Society of Nephrology
Systemic Lupus Erythematosus Research
article

C3 Glomerulonephritis and Neuromyelitis Optica in a Patient with Systemic Lupus Erythematosus (SLE)/Sjogren Overlap Syndrome

Vijaya Chelikani, Frida Rosenblum, Arun Rajasekaran
article en

Abstract

Introduction: C3 glomerulopathy (C3G) that includes dense deposit disease (DDD) and C3 glomerulonephritis (C3GN) are rare glomerular disorders triggered by dysregulation of the alternative complement pathway with an estimated incidence of 2-3 cases per million. We describe a rare case of C3GN and neuromyelitis optica in a patient with known SLE/Sjogren overlap syndrome. Case Description: 51-year-old African-American female with SLE/Sjogren overlap syndrome presented with proteinuric AKI on CKD and newly diagnosed transverse myelitis. Baseline Cr 0.8 mg/dL. Labs on admission: Cr 1.7 mg/dL, Sr albumin 2.8 g/dL, UPCR 5511 mg/g, urinalysis revealed acanthocytes. C3 152, C4 38, ANA 1:320 [speckled], ds-DNA (-), SSA > 150, SSB 106, NMO/AQP4 (+) at 1:10000. Rest of serological workup negative. No e/o infection. Kidney USG unremarkable. Kidney biopsy - LM: 35 glomeruli, no segmental or global sclerosis. Glomeruli normal, no endocapillary hypercellularity noted. IFTA <5%. Mild to moderate arterial and arteriolar sclerosis. IF: Fine granular reactivity for C3 [3+] along capillaries and in mesangium that are chunky. Rest of immunoreactants negative. Pronase IF negative. EM: Few scattered medium to large-sized electron dense deposits present in the mesangium and paramesangial area. Alternative complement pathway functional panel revealed low APFA and Fb levels and elevated C5 levels. C3GN genetic panel revealed a VUS in the THBD and MPLA gene. Patient received repeated doses of rituximab and has attained complete remission of proteinuria and resolution of AKI. Discussion: C3GN affecting younger patients usually are mediated by genetic abnormalities of the alternative complement pathway. In addition to renal manifestations, a number of other extra-renal manifestations have also been associated with C3G including retinal involvement [drusen] and lipodystrophy, particularly in DDD. To date, concomitant NMO (+) transverse myelitis presenting concomitantly with C3GN has not been described. It remains unclear if the C3G-dominant immune complex-mediated glomerulonephritis was precipitated by the underlying SLE/Sjogren overlap syndrome.

Journal of the American Society of NephrologyVol. 35(10S)
University of Alabama at Birmingham (US)
Good health and well-being
Openalex Percentile: Top 67%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.